Clinical Trial Update: Phase III Cat-PAD Study [Phase 3]

View source ↗

Summary

Circassia's Phase III Cat-PAD trial for rhinoconjunctivitis has completed and its results were posted on May 14, 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis

Drugs mentioned

• Cat-PAD

Snippet

Sponsor: Circassia Limited | Conditions: Rhinoconjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2018-05-14